{"ticker": {"uuid": "43ffd5d9-06e5-4672-b9f6-e75bc9b9192c", "symbol": "600518", "name": "Kangmei Pharmaceutical Co., Ltd.", "exchange": "SHH", "country": "CN", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Price to earnings forward of Kangmei Pharmaceutical Co., Ltd Class A \u2013 SSE:600518", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNZ0p0N01fMGFaUVg5bzJJanlHVW45MUxULU9WZGZnV0xsUUVLQTlEU1VEblI2QkxIZk9RSC1qV3MxbkxHTHB1bmRHYmxnNWVoMzNCeGprTnFheU1sTno3QUx5NEg5NEFMaHpHQVREVXJCOHN2TjF3YXRzd1gwQ0taaXdWcDFGQ1pjQURMZmVucjFYd2JoVmg0UlBrZWFsckNN?oc=5", "source_name": "TradingView", "published_at": "2026-07-13T17:37:58+00:00", "published_display": "13 Jul 2026 17:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "* ST Kangmei (600518.SH): Shennong intends to acquire 25.31% of the company's equity or become a controlling shareholder for no more than 5.419 billion yuan.", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxQZmdCMGdWalJ1a1A4VzNORGVPeTNYRmRRMlBMRnRxSlk2Qnl0N0pGVmg0R21IaGllbnM5eFZ6dUJSNkdpVG9HcUNEYW9vMnpuQXU0NmJZVzY3SjZQbnN3aDVJdURBRHJBNEc5SExpdEdNTDN2UUZqaWU0MzBNU1R5a0RPQnMwbFh1ek9Td1RiTHZZY25zUnBzX1pGOA?oc=5", "source_name": "Moomoo", "published_at": "2021-12-14T08:00:00+00:00", "published_display": "14 Dec 2021 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kangmei Ordered to Pay $385 Million to Investors", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPanRRVFliNzZMMHYyUGVRQWU4S0J3Y0ZwbnlVQzljY0c5TjVJYzIzMDFkNVpSRkNKSkY1S2ltZ0xUOHRHM3Y1V21ZNzhzZkh1cllZeUdUTVltTDVNekplRlFpQXIxd3hrYlBBQ01mVDRWWk5pNXBILUhlZFdhNmltWkZqaUZWeEpqSU9JdnR2azVqNjFMYUpRM3c3a2NGUUhBdVllbg?oc=5", "source_name": "Caixin Global", "published_at": "2021-11-13T08:00:00+00:00", "published_display": "13 Nov 2021 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Drugmaker Kangmei Seeks Stock Trading Halt After Regulator Confirms It Faked Financial Data", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3wFBVV95cUxNZkp3Y1JiS19IN0NjaEd0d0tKMjFkdXc3WGV4dmxKVXNPWkpnWWhQRFlmUWlpM3dDWnBfck5Ca0pTT0hzVm84REs3cUJQbDhQZUdNRHhUTjlZREpLWnA0aXRnbmdVR1h1Nmw4bDVYdl9NVjJ0RHYxbmJMMnVYRjJxa2RsVWhjM29GNzdtNm01eUdpUGxiYmNNQ09LSVV3Rl9EQUFfazNZcnYta1FzVDVqTUtEZm55TVhMUm8zVXpBTUI5VWxfQllPZzMwdGtjWWhFN3VEVGUwY1ZhSHdfeXFn?oc=5", "source_name": "Caixin Global", "published_at": "2019-05-18T07:00:00+00:00", "published_display": "18 May 2019 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Price to earnings forward of Kangmei Pharmaceutical Co., Ltd Class A \u2013 SSE:600518", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNZ0p0N01fMGFaUVg5bzJJanlHVW45MUxULU9WZGZnV0xsUUVLQTlEU1VEblI2QkxIZk9RSC1qV3MxbkxHTHB1bmRHYmxnNWVoMzNCeGprTnFheU1sTno3QUx5NEg5NEFMaHpHQVREVXJCOHN2TjF3YXRzd1gwQ0taaXdWcDFGQ1pjQURMZmVucjFYd2JoVmg0UlBrZWFsckNN?oc=5", "source_name": "TradingView", "published_at": "2026-07-13T17:37:58+00:00", "published_display": "13 Jul 2026 17:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "* ST Kangmei (600518.SH): Shennong intends to acquire 25.31% of the company's equity or become a controlling shareholder for no more than 5.419 billion yuan.", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxQZmdCMGdWalJ1a1A4VzNORGVPeTNYRmRRMlBMRnRxSlk2Qnl0N0pGVmg0R21IaGllbnM5eFZ6dUJSNkdpVG9HcUNEYW9vMnpuQXU0NmJZVzY3SjZQbnN3aDVJdURBRHJBNEc5SExpdEdNTDN2UUZqaWU0MzBNU1R5a0RPQnMwbFh1ek9Td1RiTHZZY25zUnBzX1pGOA?oc=5", "source_name": "Moomoo", "published_at": "2021-12-14T08:00:00+00:00", "published_display": "14 Dec 2021 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kangmei Ordered to Pay $385 Million to Investors", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPanRRVFliNzZMMHYyUGVRQWU4S0J3Y0ZwbnlVQzljY0c5TjVJYzIzMDFkNVpSRkNKSkY1S2ltZ0xUOHRHM3Y1V21ZNzhzZkh1cllZeUdUTVltTDVNekplRlFpQXIxd3hrYlBBQ01mVDRWWk5pNXBILUhlZFdhNmltWkZqaUZWeEpqSU9JdnR2azVqNjFMYUpRM3c3a2NGUUhBdVllbg?oc=5", "source_name": "Caixin Global", "published_at": "2021-11-13T08:00:00+00:00", "published_display": "13 Nov 2021 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Drugmaker Kangmei Seeks Stock Trading Halt After Regulator Confirms It Faked Financial Data", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3wFBVV95cUxNZkp3Y1JiS19IN0NjaEd0d0tKMjFkdXc3WGV4dmxKVXNPWkpnWWhQRFlmUWlpM3dDWnBfck5Ca0pTT0hzVm84REs3cUJQbDhQZUdNRHhUTjlZREpLWnA0aXRnbmdVR1h1Nmw4bDVYdl9NVjJ0RHYxbmJMMnVYRjJxa2RsVWhjM29GNzdtNm01eUdpUGxiYmNNQ09LSVV3Rl9EQUFfazNZcnYta1FzVDVqTUtEZm55TVhMUm8zVXpBTUI5VWxfQllPZzMwdGtjWWhFN3VEVGUwY1ZhSHdfeXFn?oc=5", "source_name": "Caixin Global", "published_at": "2019-05-18T07:00:00+00:00", "published_display": "18 May 2019 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 44, "total_relevant": 4, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 4, "score": 50, "total": 4, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 71, "events": [{"event": "general", "label": "Market update", "weight": 1.65, "count": 3}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 1.35, "latest_week": "2026-07-17", "one_week_move": 5.5, "four_week_move": -4.3, "twelve_week_move": -21.5, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -1.092386, "market_dynamics_buy_signal": false, "relative_strength": -23.726027, "fair_value_gap": -30.9, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 38.7971, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+5.5% over one week, -4.3% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 55, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Caixin Global", "count": 2}, {"label": "TradingView", "count": 1}, {"label": "Moomoo", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 4}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 3}, {"label": "Earnings", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "71/100 classification confidence."}, {"label": "Company focus", "value": "4", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+5.5% over one week, -4.3% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Price to earnings forward of Kangmei Pharmaceutical Co., Ltd Class A \u2013 SSE:600518"}], "updated_at": "2026-07-23T06:50:20.780147+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}